SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001837607-24-000014
Filing Date
2024-03-29
Accepted
2024-03-29 15:48:04
Documents
95
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A aeon-20230930x10qa.htm   iXBRL 10-Q/A 3051474
2 EX-31.1 aeon-20230930xex31d1.htm EX-31.1 16338
3 EX-31.2 aeon-20230930xex31d2.htm EX-31.2 15938
4 EX-32.1 aeon-20230930xex32d1.htm EX-32.1 8652
5 EX-32.2 aeon-20230930xex32d2.htm EX-32.2 8104
  Complete submission text file 0001837607-24-000014.txt   13355088

Data Files

Seq Description Document Type Size
6 EX-101.SCH aeon-20230930.xsd EX-101.SCH 105558
7 EX-101.CAL aeon-20230930_cal.xml EX-101.CAL 44853
8 EX-101.DEF aeon-20230930_def.xml EX-101.DEF 492949
9 EX-101.LAB aeon-20230930_lab.xml EX-101.LAB 733694
10 EX-101.PRE aeon-20230930_pre.xml EX-101.PRE 654404
99 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20230930x10qa_htm.xml XML 2475268
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40021 | Film No.: 24804004
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)